
mabtics
Daejeon, South Korea · mabtics.co.kr
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
MabTics develops antibody therapeutics for vascular diseases and cancers, with a focus on vessel normalization and Tie2 signaling. It is based in Daejeon, Republic of Korea, and works on mono- and bispecific antibodies for indications with unmet medical needs.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody therapeutics development
Develops novel antibody therapeutics for vascular diseases and cancers with unmet medical needs.
EAGLES™ platform
Uses the EAGLES™ platform for antibody selection and development.
Vessel normalization technology
Develops Tie2-activating antibody approaches for vessel normalization.
What they work on
- Modalities
- Antibody, Bispecific
- Therapeutic areas
- vascular diseases, cancers, acute kidney injury, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, thrombosis, thromboinflammatory diseases
- Sites
- Daejeon, Republic of Korea
- Founded
- 2022
Similar labs. Abnova, AbTherx, Alphalyse, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from mabtics.co.kr. Work here? Claim this listing.